NCT06243835View on ClinicalTrials.gov

A Study to Test the Effects of Kindolor At Different Doses in Healthy Adults

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 21, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
Chronic Pain
Interventions
DRUG

Kindolor Tosylate

Kindolor Tosylate enteric coated tablets containing the specified amount of drug product

DRUG

Placebo

Placebo enteric coated tablets identically matched to the Kindolor Tosylate tablets with equal amount of Prosolv SMCC replacing the Kindolor Tosylate

Trial Locations (1)

92037

The Altman Clinical and Translational Research Institute, La Jolla

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Lohocla Research Corporation

INDUSTRY